文献速递腹部技术与安全US

声学结构定量与点剪切波速度测量评估乙型病毒性肝炎肝纤维化的对比研究

Acoustic Structure Quantification Versus Point Shear Wave Speed Measurement for the Assessment of Liver Fibrosis in Viral Hepatitis B.
PubMed 文献 · Ultrasound Med Biol · 2018-03-30

研究纳入104例慢性乙型肝炎患者和30例健康对照,比较声学结构定量(ASQ)与点剪切波速度测量(PSWSM)评估肝纤维化分期的价值,以METAVIR病理评分为基准。ASQ整合指标与SWS均与纤维化分期良好相关(r=0.682与r=0.651,均p<0.001);PSWSM对轻度纤维化(F≥1)和肝硬化(F=4)的AUC优于ASQ,两者联合可提高重度纤维化(F≥3)的诊断准确性。

要点

  • PSWSM鉴别轻度肝纤维化(F≥1)和肝硬化(F=4)的AUC分别为0.854和0.971,优于ASQ。
  • ASQ整合指标与SWS均与METAVIR纤维化分期良好相关(r=0.682与0.651,均p<0.001)。
  • PSWSM与ASQ联合可提高重度肝纤维化(F≥3)的诊断准确性。

核心结论

  • ASQ与PSWSM均为评估慢性乙型肝炎患者肝纤维化的有前景超声方法,PSWSM在识别轻度纤维化(F≥1)和肝硬化(F=4)方面较ASQ更有价值,两者联合可提高重度纤维化(F≥3)的诊断准确性。

研究设计与样本

  • 共纳入104例慢性乙型肝炎患者和30例健康对照,均行ASQ和PSWSM检查;ASQ获取7个定量参数并经主成分分析建立整合指标,PSWSM获取剪切波速度(SWS,m/s);以METAVIR病理肝纤维化评分为基准。

诊断标准与关键数值

  • ASQ与PSWSM诊断轻度肝纤维化(F≥1)的AUC分别为0.705与0.854(p=0.045)。
  • ASQ与PSWSM诊断显著肝纤维化(F≥2)的AUC分别为0.813与0.743(p=0.115)。
  • ASQ与PSWSM诊断重度肝纤维化(F≥3)的AUC分别为0.839与0.857(p=0.417)。
  • ASQ与PSWSM诊断肝硬化(F=4)的AUC分别为0.874与0.971(p=0.016)。
  • ASQ整合指标与肝纤维化分期的相关系数r=0.682(p<0.001),SWS与肝纤维化分期的相关系数r=0.651(p<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

This study was conducted to evaluate the value of acoustic structure quantification (ASQ) technology versus that of point shear wave speed measurement (PSWSM) imaging technology for the assessment of liver fibrosis stage. A total of 104 patients with chronic hepatitis B (CHB) and 30 healthy control patients underwent ASQ and PSWSM examinations. Seven quantitative parameters were obtained from ASQ, and a principal component analysis was used to establish the integrative indicators. A quantitative parameter, known as the shear wave speed (SWS, m/s), was obtained from the PSWSM. The METAVIR scores for the assessment of pathologic liver fibrosis were used as a benchmark. Liver fibrosis stages exhibited a good correlation with the integrative indicators and SWS (r = 0.682, p <0.001; r = 0.651, p <0.001). The areas under the receiver operating characteristic curves for ASQ and PSWSM were 0.705 and 0.854 for mild liver fibrosis (F ≥ 1, p = 0.045), 0.813 and 0.743 for significant liver fibrosis (F ≥ 2, p = 0.115), 0.839 and 0.857 for severe liver fibrosis (F ≥ 3, p = 0.417) and 0.874 and 0.971 for liver cirrhosis (F = 4, p = 0.016), respectively. In conclusion, both ASQ and PSWSM were promising ultrasonic methods for assessing liver fibrosis in patients with CHB; however, PSWSM was more valuable for identifying mild liver fibrosis (F ≥ 1) and cirrhosis (F = 4) than ASQ, and the combination of PSWSM and ASQ improved the accuracy of diagnosing severe liver fibrosis (F ≥ 3).

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Liu J, Ren W, Ai H, et al. Acoustic Structure Quantification Versus Point Shear Wave Speed Measurement for the Assessment of Liver Fibrosis in Viral Hepatitis B. Ultrasound Med Biol. 2018. PMID: 29609809. doi:10.1016/j.ultrasmedbio.2018.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。